Cargando…
Lipid Control in Patients with Diabetes across Primary and Tertiary Government Health Sectors in Dubai: A Five-year Pattern
OBJECTIVES: A key aspect for the prevention of vascular complications in diabetes is control of hyperlipidemia, and that has always been a global challenge. The prevalence of diabetes mellitus in the UAE is estimated to be 18.98%. However, despite this high prevalence, very few studies have evaluate...
Autores principales: | Abdelgadir, Elamin, Alsaeed, Maryam, Hafidh, Khadija, Bashier, Alaaeldin, Rashid, Fauzia, Altayb, Fawzi, Sayyah, Fatima, Farooqi, Muhammad H., Alawadi, Fatheya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
OMJ
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6642714/ https://www.ncbi.nlm.nih.gov/pubmed/31360316 http://dx.doi.org/10.5001/omj.2019.58 |
Ejemplares similares
-
Glycemic Control in Patients with Diabetes across Primary and Tertiary Government Health Sectors in the Emirate of Dubai, United Arab Emirates: A Five-Year Pattern
por: Alawadi, Fatheya, et al.
Publicado: (2019) -
Consensus recommendations for management of patients with type 2 diabetes mellitus and cardiovascular diseases
por: Bashier, Alaaeldin, et al.
Publicado: (2019) -
Efficacy and Safety of SGLT2 Inhibitors in Reducing Glycated Hemoglobin and Weight in Emirati Patients With Type 2 Diabetes
por: Bashier, Alaaeldin, et al.
Publicado: (2017) -
Peri-portal lymphedema in association with an acute adrenal insufficiency: case report
por: Abdelgadir, Elamin Ibrahim Elamin, et al.
Publicado: (2014) -
SGLT-2 Inhibitors and Cardiovascular Protection: Lessons and Gaps in Understanding the Current Outcome Trials and Possible Benefits of Combining SGLT-2 Inhibitors With GLP-1 Agonists
por: Abdelgadir, Elamin, et al.
Publicado: (2018)